Status | Study |
RECRUITING |
Study Name: Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease Condition: Fabry Disease Date: 2023-09-11 |
RECRUITING |
Study Name: Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing Condition: Fabry Disease Date: 2023-01-12 Interventions: baseline cMRI, vascular reactivity studies, and CPET |
Active, not recruiting |
Study Name: 4D-310 in Adults With Fabry Disease and Cardiac Involvement Condition: Fabry Disease Date: 2022-11-04 Interventions: Interventional |
RECRUITING |
Study Name: Fabry Exercise Intolerance Study Condition: Fabry Disease Date: 2022-05-17 Interventions: Exercise test with step-change from rest to a relatively low constant workload. |
COMPLETED |
Study Name: A Study of REPLAGAL� in Treatment-naive Chinese Participants With Fabry Disease Condition: Fabry Disease Date: 2021-07-21 Interventions: Participants will receive REPLAGAL infusion intravenously. |
RECRUITING |
Study Name: Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients Condition: Fabry Disease Date: 2021-03-16 Interventions: This is a non-interventional study |
Completed |
Study Name: A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease Condition: Fabry Disease Date: 2016-10-10 Interventions: Drug: Lucerastat Hard gelatin |
Recruiting |
Study Name: Fabry Disease in Cerebrovascular Disease Condition: Fabry Disease Date: 2016-08-04 Interventions: Genetic: 26 common Fabry mutation types in Taiwan Historical DNA samples from projects 103-3254C (98-388 |
Recruiting |
Study Name: Evaluation of the Gastrointestinal Manifestation of Fabry's Disease Condition: Fabry's Disease Date: 2016-06-03 Interventions: Device: Smartpill The SmartPil |
Recruiting |
Study Name: Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease Condition: Fabry Disease Date: 2016-04-15 Interventions: Biological: Lentivirus Alpha-gal A transduced stem cells |